Veradermics Prices Upsized Public Offering, Enters Private Placement

MT Newswires Live04-30

Veradermics (MANE) said late Wednesday it priced its upsized public offering of 3.8 million common shares at $100 per share for gross proceeds of about $384.4 million.

The company has provided the underwriters a 30-day overallotment option to buy up to 576,568 additional common shares, it said.

Concurrently, the company entered a securities purchase deal to sell a total of 300,000 pre-funded warrants at $99.99999 per share to certain entities affiliated with Suvretta Capital in a private placement, with expected gross proceeds of roughly $30 million, according to Veradermics.

Veradermics said it anticipates closing the offering and the private placement on Friday.

Shares of the company were down 3.3% in premarket trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment